Heterogeneity in responses by primary adult human colonic epithelial cells to purified enterotoxin of Bacteroides fragilis

Gut

Volumn 43, Issue 5, 1998, Pages 651-655

  Sanfilippo, L ^a   Baldwin, T J ^b   Menozzi, M G ^c   Borriello, S P ^b   Mahida, Y R ^a,d  

^a Division of Gastroenterology

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF PARMA   (Italy)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Apoptosis; Bacteroides fragilis; Enterotoxin; Epithelial cells

Indexed keywords

ENTEROTOXIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BACTERIAL VIRULENCE; BACTEROIDES FRAGILIS; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CYTOPATHOGENIC EFFECT; DIARRHEA; EPITHELIUM CELL; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TOXIN ANALYSIS;

EID: 0031744185     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.5.651     Document Type: Article

References (34)

1. Moore WEC, Holdeman LV. Human flora: the normal flora of twenty Japanese Hawaiians. Appl Microbiol 1974;27:961-79.
2. Moore WEC, Cato EP, Holdeman LV. Some current concepts in intestinal bacteriology. Am J Clin Nutr 1978;31:S33-42.
3. Myers LL, Firehammer BD, Shoop DS, et al. Bacteroides fragilis: a possible cause of acute diarrheal disease in newborn lambs. Infect Immun 1984;44:241-4.
4. Myers LL, Shoop DS, Firehammer BD, et al. Association of enterotoxigenic Bacteroides fragilis with diarrhea disease in calves. J Infect Dis 1985;152:344-7.
5. Myers LL, Shoop DS. Association of enterotoxigenic Bacteroides fragilis with diarrhea disease in young pigs. Am J Vet Res 1987;48:774-5.
6. Myers LL, Shoop DS, Byars TD. Diarrhea associated with enterotoxigenic Bacteroides fragilis in foals. Am J Vet Res 1987;48:1565-7.
7. Weikel CS, Grieco FD, Reuben J, et al. Human colonic epithelial cells, HT-29, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun 1992;60:321-7.
8. Pantosti A, Cerquetti M, Colangeli R, et al. Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by the HT-29 cytotoxicity assay. J Med Microbiol 1994;41:191-6.
9. Mundy LM, Sears CL. Detection of toxin production by Bacteroides fragilis: assay development and screening of extra-intestinal clinical isolates. Clin Infect Dis 1996;23: 269-76.
10. Van Tassel RL, Lyerly DM, Wilkins TD. Purification and characterization of an enterotoxin from Bacteroides fragilis. Infect Immun 1992;60:1343-50.
11. Moncrief JS, Obiso R, Barroso LA, et al. The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect Immun 1995;63:175-81.
12. Obiso RJ, Lyerly DM, Van Tassel RL, et al. Proteolytic activity of the Bacteroides fragilis enterotoxin causes secretion and intestinal damage in vivo. Infect Immun 1995;63: 3820-6.
13. Sack RB, Myers LL, Hill JA, et al. Enterotoxigenic Bacteroides fragilis: epidemiologic studies of its role as a human diarrhoeal pathogens. J Diarrhoeal Dis Res 1992;10: 4-9.
14. Sack RB, Albert MJ, Alam K, et al. Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study. J Clin Microbiol 1994;32:960-3.
15. San Joakin VH, Griffis JC, Lee C, et al. Association of Bacteroides fragilis with childhood diarrhea. Scand J Infect Dis 1995;27:211-15.
16. Myers LL, Shoop DS, Stackhouse LL, et al. Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol 1987;25:2330-3.
17. Pantosti A, Menozzi MG, Frate A, et al. Detection of enterotoxigenic Bacteroides fragilis and its toxin in stool sample from adults and children in Italy. Clin Infect Dis 1997;24:12-16.
18. Wells CL, Van De Westerlo EMA, Jechorek RP, et al. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology 1996;110:1429-37.
19. Van Tassel RL, Lyerly DM, Wilkins TD. Production of antisera against the enterotoxin of Bacteroides fragilis and their use in a cytotoxicity neutralization assay of HT-29 cells. Clin Diagn Lab Immun 1994;1:473-6.
20. Mahida YR, Makh S, Gray T, et al. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 1996;38:337-47.
21. Robinson G, Gray T. Electron microscopy 2. Tissue preparation, sectioning and staining. In: Bancroft JD, Stevens A, eds. Theory and practice of histological techniques. 3rd edn. London: Churchill Livingstone, 1990:525-62.
22. Collins JE, Bergeland ME, Myers LL, et al. Exfoliating colitis associated with enterotoxigenic Bacteroides fragilis in a piglet. J Vet Diagn Invest 1989;1:349-51.
23. Myers LL, Collins JE, Snoop DS. Ultrastructural lesions of enterotoxigenic Bacteroides fragilis in rabbits. Vet Pathol 1991;28:336-8.
24. Myers LL, Shoop DS, Collins JE, et al. Diarrheal disease caused by enterotoxigenic Bacteroides fragilis in infant rabbits. J Clin Microbiol 1989;27:2025-30.
25. Myers LL, Shoop DS, Collins JE. Rabbit model to evaluate enterovirulence of Bacteroides fragilis. J Clin Microbiol 1990;28:1658-60.
26. Borriello SP, Davies HA, Kamiya S, et al. Virulence factors of Clostridium difficile. Rev Infect Dis 1991;12:S185-91.
27. Branka J-E, Vallette G, Jarry A, et al. Early functional effects of Clostridium difficile toxin A on human colonocytes. Gastroenterology 1997;112:1887-94.
28. McAlindon M, Mahida YR. Cytokines and the gut. Eur J Gastroenterol Hepatol 1997;9:1045-50.
29. Riegler M, Sedivy T, Sogukoglu T, et al. Differential effects of Bacteroides fragilis toxin (BFT)-2 and Clostridium difficile toxin A and B on human colonic mucosa in vitro [abstract]. Gastroenterology 1997;112:A1072.
30. Obiso RJ, Azghani AO, Wilkins TD. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect Immun 1997;65:1431-9.
31. Mahida YR, Galvin A, Gray T, et al. Migration of human intestinal lamina propria lynphocytes, macrophages and eosinophils following the loss of surface epithelial cells. Clin Exp Immunol 1997;109:377-86.
32. Mahida YR. Mechanisms of host protection and inflammation in the gastrointestinal tract. J R Coll Physicians Lond 1997;31:493-7.
33. Gerding DN. Disease associated with Clostridium difficile infection. Ann Intern Med 1989;110:255-7.
34. Kerr RB, McLaughlin DI, Sonnenberg LW. Control of Clostridium difficile colitis outbreak by treating asymptomatic carriers with metronidazole. Am J Infect Control 1990;18:332-5.